Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials.

ABSTRACT:

Objectives

To report the results of a survey conducted among Mayo Clinic medical oncologists, hematologists, and cancer prevention specialists to better understand the current practice of determining whether an adverse event that a patient experience in a clinical trial is related to the drug under investigation, a process commonly known as attribution, as well as to formulate recommendations for an improved system.

Patients and methods

An electronic survey was developed and conducted (from August 2 through 29, 2017) among 165 medical oncologists, hematologists, and cancer prevention specialists at the 3 Mayo Clinic sites: Rochester, Minnesota; Scottsdale, Arizona; and Jacksonville, Florida. The survey included 21 items that queried clinicians about their clinical practice a

SUBMITTER: Le-Rademacher JG 

PROVIDER: S-EPMC6543498 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature